AACR Applauds Biden Administration for its Plan to Protect the Public from the Dangers of Menthol Cigarettes and Flavored Cigars
The announcement was in response to a 2013 citizen petition that outlined the science and called for a ban...
The announcement was in response to a 2013 citizen petition that outlined the science and called for a ban...
PHILADELPHIA – When given a choice, most individuals with an average risk of colorectal cancer said they would prefer...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced that John D. Carpten, PhD, FAACR, has been...
David A. Tuveson, MD, PhD, FAACR, inaugurated as President PHILADELPHIA — The American Association for Cancer Research (AACR) welcomes...
PHILADELPHIA – Men who had a high genetic risk of developing prostate cancer were less likely to develop a...
PHILADELPHIA – A combination of copanlisib (Aliqopa) and rituximab led to a 48 percent reduction in the risk of...
PHILADELPHIA – Tumor mutational burden (TMB) was an accurate predictor of response to treatment with immune checkpoint inhibitors for...
PHILADELPHIA – A liquid biopsy test to assess plasma cell-free DNA (cfDNA) integrity could improve the accuracy of magnetic...
PHILADELPHIA – Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumor tissue identified the transcription factor...
PHILADELPHIA – Racial differences in genetic mutations were observed among early-onset colorectal cancers (CRC), according to data presented during...